New Study accepted by the FDA from Marc Sakwa, MD, William Beaumont Hospitals. The purpose of the study is to demonstrate that Custodiol-HTK is not inferior to cold cardioplegic solution in patients undergoing cardiovascular surgery requiring cardioplegic arrest.